Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia

Journal of Molecular Endocrinology

Volumn 25, Issue 1, 2000, Pages 109-119

  Bakke, I ^a   Sandvik, A K ^a   Waldum, H L ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFIBRATE; OCTREOTIDE; PEROXISOME PROLIFERATOR;

ANIMAL EXPERIMENT; ARTICLE; CELL HYPERPLASIA; DRUG EFFECT; ENTEROCHROMAFFIN CELL; FEMALE; GASTRIN BLOOD LEVEL; GASTRIN CELL; HISTAMINE BLOOD LEVEL; HYPERGASTRINEMIA; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033867353     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0250109     Document Type: Article

References (41)

1. Neuroendocrine cells in the prostate of the rat, guinea pig, cat, and dog
2. Morphometry of gastric endocrine cells in hypergastrinemic patients treated with the somatostatin analogue octreotide
3. Modlin 1M 1996 Somatostatin receptor regulation of gastric enterochromaffin-like cell transformation to gastric carcinoid
4. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alplha, -beta, and -gamma in the adult rat
5. Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: Establishment of a dose response relationship
6. Action of somatostatin analogue (SMS) on the growth-promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behaviour
7. The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal nucleic acid
8. Somatostatin cells in the oxyntic mucosa of hypo- or hypergastrinemic rats
9. Oxyntic endocrine cells of hypergastrinaemic patients. Differential response to antrectomy or octreotide
10. Reversal by omeprazole of the depression of gastrin cell function by fasting in the rat
11. The effect of ciprofibrate on gastric secretion in the rat
12. Assessment of gastric antisecretory effects of phenoxyisobutyrate derivatives in the rat and the mouse
13. Species varlation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmoset
14. Potentiating hypergastrinemic effect by the peroxisome proliferator ciprofibrate and omeprazole in the rat
15. GRP-producing nerves control antral somatostatin and gastrin secretion in pigs
16. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
17. Inhibition of gastrin gene expression by somatostatin
18. Effect of a somatostatin analogue (SMS 201-995) on antral gastrin cell hyperplasia and hypergastrinemia induced by a histamine H2-receptor antagonist
19. 125I-gastrin, using Iodo-gen as oxidizing agent, and the use of this tracer in receptor studies
20. Orphan nuclear receptors: Shifting endocrinology into reverse
21. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
22. Gastrin and somatostatin in the rat antrum. The effect of removal of acid-secreting mucosa
23. The peroxisome-proliferator ciprofibrate induces hypergastrinemia without raising gastric pH
24. Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas
25. Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis
26. Effect of short-term administration of dexamethasone on canine antral gastrin gene expression
27. Complex co-localization of chromogranins and neurohormones in the human gastrointestinal tract
28. Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach
29. Gastrin and somatostatin secretion by perfused rat stomach: Functional linkage of antral peptides
30. The effect of somatostatin on baseline and stimulated acid secretion and vascular histamine release from the totally isolated vascularly perfused rat stomach
31. The effect of gastrin-releasing peptide on acid secretion and the release of gastrin, somatostatin, and histamine in the totally isolated, vascularly perfused rat stomach
32. Bombesin inhibits histamine release from the rat oxyntic mucosa by a somatostatin-dependent mechanism
33. Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate
34. Gastric endocrine cell typing at the light microscope level
35. Inhibition of gastrin-stimulated enterochromaffin-like cell proliferation and mucosal histamine production in the rat stomach by the somatostatin analogue octreotide
36. Histamine and gastrin in plasma of patients with upper gastrointestinal diseases
37. The effect of the peroxisome proliferator ciprofibrate on the gastric mucosa and particularly the gastrin cell
38. Active immunization against somatostatin alters regulation of gastrin in response to gastric acid secretagogues
39. Regulation of rat antral gastrin and somatostatin gene expression during starvation and after refeeding
40. Alterations in serum gastrin levels and antral G- and D-cell population following corticosteroid administration. RIA and immunocytochemical long-term study in guinea pigs
41. Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum